Management of Candida albicans donor-to-host transmission following penetrating keratoplasty.
Kawakita
Tetsuya
T
Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Sugano 5-11-13, Ichikawa, Chiba, 272-8513, Japan. kawatetsu@gmail.com.|Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan. kawatetsu@gmail.com.
Kawashima
Motoko
M
Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Sugano 5-11-13, Ichikawa, Chiba, 272-8513, Japan.
Shimazaki
Jun
J
Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Sugano 5-11-13, Ichikawa, Chiba, 272-8513, Japan.|Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
D000935:Antifungal Agents / Q000627:therapeutic use*; D002176:Candida albicans / Q000302:isolation & purification; D002177:Candidiasis / Q000188:drug therapy / Q000382:microbiology / Q000635:transmission*; D003320:Corneal Ulcer / Q000188:drug therapy* / Q000382:microbiology*; D018562:Disease Transmission, Infectious; D015821:Eye Infections, Fungal / Q000188:drug therapy / Q000382:microbiology / Q000635:transmission*; D006801:Humans; D007640:Keratoconus / Q000601:surgery; D015948:Keratoplasty, Penetrating / Q000009:adverse effects*; D008297:Male; D008825:Miconazole / Q000627:therapeutic use; D008875:Middle Aged; D014019:Tissue Donors
D000935:Antifungal Agents; D008825:Miconazole